Tim Anderson
Tim Anderson
Timothy Devon Andersonis an American professional baseball shortstop for the Chicago White Sox of Major League Baseball. Anderson played college baseball at East Central Community College, and was selected in the first round of the 2013 MLB draft by the White Sox. He made his MLB debut on June 10, 2016...
ProfessionBaseball Player
Date of Birth23 June 1993
benefits move proof pudding
The proof of the pudding will be what are the benefits at the checkpoint. Will you be able to move through faster? If so, I think this will be a very well-received program.
good negative people quarter time wary
The quarter was good in that they didn't have anything negative at a time when a lot of people are wary about earnings,
base business coming good names
There are some names out there, like Wyeth, for example, that, you know, the base business is in good enough shape, where they actually don't need much coming out of the pipeline,
case cold hope
Our hope (in this case) is we will get a cold hit, ... It's important that we put this case to rest.
fda follow full
I think that the FDA will follow up with full approval,
washed
I think that the stock's probably washed out for a while,
dozen fairly half jump
Half a dozen will jump in fairly quickly.
earnings growth guidance revenue seems tells
Merck tells an interesting story, yet the five-year revenue and earnings growth guidance seems far-fetched.
beat company earnings key sale several
While the company beat earnings (expectations), sale for several key franchises lagged our estimates.
hoping
I'm hoping they'll come out with more than they did on Jan. 20, when they weren't as forthcoming as I was hoping.
cancer data revenue translate
While the breast cancer data is interesting, we don't think it will translate into a significant new revenue stream.
bad good negative products
You've got the good with the bad with the sector, ... The good being that you've got good products and fundamentals and the bad being that you've got some negative headlines.
acting companies company couple facing happen happens ironically run supposed turnaround
The company's not going out of business, but ironically it's acting like a cyclical, which drug companies aren't supposed to do. The turnaround may not happen for a couple of years, but it's a well run company that just happens to be facing a lot of problems.
bristol company concern decent drop far next patent shoe
The concern is that Bristol could be the next shoe to drop as far as patent expiration and reining in the numbers, ... But the company has a pretty decent late-stage pipeline.